370 related articles for article (PubMed ID: 25647720)
1. Ras suppressor-1 promotes apoptosis in breast cancer cells by inhibiting PINCH-1 and activating p53-upregulated-modulator of apoptosis (PUMA); verification from metastatic breast cancer human samples.
Giotopoulou N; Valiakou V; Papanikolaou V; Dubos S; Athanassiou E; Tsezou A; Zacharia LC; Gkretsi V
Clin Exp Metastasis; 2015 Mar; 32(3):255-65. PubMed ID: 25647720
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Breast Cancer Cell Invasion by Ras Suppressor-1 (RSU-1) Silencing Is Reversed by Growth Differentiation Factor-15 (GDF-15).
Gkretsi V; Louca M; Stylianou A; Minadakis G; Spyrou GM; Stylianopoulos T
Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30621163
[TBL] [Abstract][Full Text] [Related]
3. Depletion of Ras Suppressor-1 (RSU-1) promotes cell invasion of breast cancer cells through a compensatory upregulation of a truncated isoform.
Gkretsi V; Kalli M; Efstathiades C; Papageorgis P; Papanikolaou V; Zacharia LC; Tsezou A; Athanassiou E; Stylianopoulos T
Sci Rep; 2019 Jul; 9(1):10050. PubMed ID: 31296919
[TBL] [Abstract][Full Text] [Related]
4. Identification of Ras suppressor-1 (RSU-1) as a potential breast cancer metastasis biomarker using a three-dimensional in vitro approach.
Gkretsi V; Stylianou A; Louca M; Stylianopoulos T
Oncotarget; 2017 Apr; 8(16):27364-27379. PubMed ID: 28423706
[TBL] [Abstract][Full Text] [Related]
5. The impact of angio-associated migratory cell protein (AAMP) on breast cancer cells in vitro and its clinical significance.
Yin Y; Sanders AJ; Jiang WG
Anticancer Res; 2013 Apr; 33(4):1499-509. PubMed ID: 23564791
[TBL] [Abstract][Full Text] [Related]
6. Tumor-suppressive microRNA-34a inhibits breast cancer cell migration and invasion via targeting oncogenic TPD52.
Li G; Yao L; Zhang J; Li X; Dang S; Zeng K; Zhou Y; Gao F
Tumour Biol; 2016 Jun; 37(6):7481-91. PubMed ID: 26678891
[TBL] [Abstract][Full Text] [Related]
7. Ras suppressor 1 long form (RSU1L) silencing promotes apoptosis in invasive breast cancer cells.
Christou C; Christodoulou MI; Zaravinos A; Gkretsi V
Cell Signal; 2023 Jan; 101():110522. PubMed ID: 36375714
[TBL] [Abstract][Full Text] [Related]
8. The mRNA expression of inhibitors of DNA binding-1 and -2 is associated with advanced tumour stage and adverse clinical outcome in human breast cancer.
Wazir U; Jiang WG; Sharma AK; Newbold RF; Mokbel K
Anticancer Res; 2013 May; 33(5):2179-83. PubMed ID: 23645773
[TBL] [Abstract][Full Text] [Related]
9. Potential prognostic biomarker CD73 regulates epidermal growth factor receptor expression in human breast cancer.
Zhi X; Wang Y; Yu J; Yu J; Zhang L; Yin L; Zhou P
IUBMB Life; 2012 Nov; 64(11):911-20. PubMed ID: 23086814
[TBL] [Abstract][Full Text] [Related]
10. Identification of novel biomarkers associated with poor patient outcomes in invasive breast carcinoma.
Canevari RA; Marchi FA; Domingues MA; de Andrade VP; Caldeira JR; Verjovski-Almeida S; Rogatto SR; Reis EM
Tumour Biol; 2016 Oct; 37(10):13855-13870. PubMed ID: 27485113
[TBL] [Abstract][Full Text] [Related]
11. Prognostic and biological significance of microRNA-127 expression in human breast cancer.
Wang S; Li H; Wang J; Wang D; Yao A; Li Q
Dis Markers; 2014; 2014():401986. PubMed ID: 25477702
[TBL] [Abstract][Full Text] [Related]
12. Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma.
Elloul S; Elstrand MB; Nesland JM; Tropé CG; Kvalheim G; Goldberg I; Reich R; Davidson B
Cancer; 2005 Apr; 103(8):1631-43. PubMed ID: 15742334
[TBL] [Abstract][Full Text] [Related]
13. Increased claudin-4 expression is associated with poor prognosis and high tumour grade in breast cancer.
Lanigan F; McKiernan E; Brennan DJ; Hegarty S; Millikan RC; McBryan J; Jirstrom K; Landberg G; Martin F; Duffy MJ; Gallagher WM
Int J Cancer; 2009 May; 124(9):2088-97. PubMed ID: 19142967
[TBL] [Abstract][Full Text] [Related]
14. Role of PINCH and its partner tumor suppressor Rsu-1 in regulating liver size and tumorigenesis.
Donthamsetty S; Bhave VS; Mars WM; Bowen WC; Orr A; Haynes MM; Wu C; Michalopoulos GK
PLoS One; 2013; 8(9):e74625. PubMed ID: 24058607
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-30a suppresses breast tumor growth and metastasis by targeting metadherin.
Zhang N; Wang X; Huo Q; Sun M; Cai C; Liu Z; Hu G; Yang Q
Oncogene; 2014 Jun; 33(24):3119-28. PubMed ID: 23851509
[TBL] [Abstract][Full Text] [Related]
16. Mitogen-inducible Gene-2 (MIG2) and migfilin expression is reduced in samples of human breast cancer.
Gkretsi V; Papanikolaou V; Zacharia LC; Athanassiou E; Wu C; Tsezou A
Anticancer Res; 2013 May; 33(5):1977-81. PubMed ID: 23645746
[TBL] [Abstract][Full Text] [Related]
17. PINCH-1 promotes Bcl-2-dependent survival signalling and inhibits JNK-mediated apoptosis in the primitive endoderm.
Montanez E; Karaköse E; Tischner D; Villunger A; Fässler R
J Cell Sci; 2012 Nov; 125(Pt 21):5233-40. PubMed ID: 22946061
[TBL] [Abstract][Full Text] [Related]
18. P14ARF is down-regulated during tumour progression and predicts the clinical outcome in human breast cancer.
Wazir U; Jiang WG; Yasaei H; Linne H; Newbold RF; Mokbel K
Anticancer Res; 2013 May; 33(5):2185-9. PubMed ID: 23645774
[TBL] [Abstract][Full Text] [Related]
19. Role of PRL-3, Snail, Cytokeratin and Vimentin expression in epithelial mesenchymal transition in breast carcinoma.
Patel NA; Patel PS; Vora HH
Breast Dis; 2015; 35(2):113-27. PubMed ID: 25547164
[TBL] [Abstract][Full Text] [Related]
20. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
